Kwan Ho Tang, PhDNew York UniversityNew York, NY, United States 2019 Scientific Scholar Award Research in Focus: Novel therapies to treat ovarian cancer Targeting SHP2 and MEK in High-Grade Serous Ovarian Cancer High-grade serous ovarian cancer is the most lethal gynecological disease. Dr. Tang and colleagues have shown in that a combination treatment of SHP2 inhibitor […]
Read MoreStarting April 1, 2025, the Rivkin Center’s ovarian cancer research funding, global symposium and fundraising activities will continue under the leadership of Ovarian Cancer Research Alliance (OCRA).
